Enhance your pharmacovigilance operations with our comprehensive training course tailored for pharmaceutical and biologic companies. Gain insights into US, EU, and UK drug safety regulatory ...

Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance ... operations to align with evolving US, EU, and UK compliance standards and ...

DUBLIN--(BUSINESS WIRE)--The "Global Regulatory Requirements for Drug Safety & Pharmacovigilance ... and biologic companies operating in the US and EU an introduction to product safety regulatory ...

New Drug Submission filed by Lipocine's licensing partner Verity Pharma <li /> Over 700,000 total prescriptions written annually for test ...

Please note that Alnylam also markets Amvuttra, the company’s lead drug, in the United States ... also currently under review in the United States. If the regulatory applications in the EU ...

GSK plc GSK announced that the FDA has accepted its regulatory filing, seeking the approval ... Please note that Nucala is already approved in the United States for four IL-5-mediated conditions ...

U.S. Food and Drug Administration advisers unanimously recommended on Thursday that COVID-19 vaccines for the 2025-26 period ...

President Donald J. Trump has signed an executive order that seeks to do what past presidents, including Trump himself in his previous administration, did not succeed in doing: increasing US ...

The terms of the IPO were not disclosed in the filing. Sign up here. Strong equity markets, falling interest rates and hopes of a friendlier regulatory ... and oral drugs to treat obesity, based ...

Yet the costs of developing new drugs in the U.S. needn’t be so high. They are driven up, in part, by increasing regulatory requirements that burden early-stage drug discovery in America.